Invitrogen™ CD134 (OX40) Monoclonal Antibody (OX40), APC, eBioscience™

Description

Description: The monoclonal antibody OX40 reacts with rat CD134, a 50-kDa glycoprotein belonging to the TNFR superfamily. CD134, which is also known as OX40, is expressed on activated T cells, TH1, TH2, TH17, and Tregs, but not on naive CD4 or CD8 T cells or most memory cells. CD134 is also inducible on NKT cells, neutrophils, and NK cells. CD134 binds to CD252 (OX40L) to mediate T cell expansion and survival, as well as memory T cell generation. Finally, CD134 is involved in Treg suppression and tolerance. Applications Reported: This OX40 antibody has been reported for use in flow cytometric analysis. Applications Tested: This OX40 antibody has been tested by flow cytometric analysis of stimulated rat splenocytes. This can be used at less than or equal to 0.125 μg per test. A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. Excitation: 633-647 nm; Emission: 660 nm; Laser: Red Laser. Filtration: 0.2 μm post-manufacturing filtered.

OX40 is a protein receptor found on the surface of T cells, a type of white blood cell that plays a crucial role in the immune system. When activated, OX40 promotes the proliferation and survival of T cells, leading to a stronger immune response against cancer cells and infectious agents. OX40 agonists, which are drugs that activate OX40, have shown promising results in preclinical and clinical studies as a potential immunotherapy for cancer. They can enhance the efficacy of other cancer treatments such as chemotherapy and checkpoint inhibitors, and may also have applications in autoimmune diseases and allergies.